Comparison of eleven commercial tests for Chlamydia pneumoniae-specific immunoglobulin G in asymptomatic healthy individuals.
about
Evaluation and optimization of a commercial enzyme linked immunosorbent assay for detection of Chlamydophila pneumoniae IgA antibodiesPrevalence and persistence of Chlamydia pneumoniae antibodies in healthy laboratory personnel in Finland.Characterization of the humoral immune response to Chlamydia outer membrane protein 2 in chlamydial infection.Comparison of quantitative and semiquantitative enzyme-linked immunosorbent assays for immunoglobulin G against Chlamydophila pneumoniae to a microimmunofluorescence test for use with patients with respiratory tract infections.High seroprevalence of Mycoplasma pneumoniae IgM in acute Q fever by enzyme-linked immunosorbent assay (ELISA).Genetic and infectious profiles influence cerebrospinal fluid IgG abnormality in Japanese multiple sclerosis patientsImpact of serological methodology on assessment of the link between Chlamydia pneumoniae and vascular diseases.Acute respiratory infection due to Chlamydia pneumoniae: current status of diagnostic methods.Recent Chlamydia pneumoniae infection is highly associated with active ankylosing spondylitis in a Chinese cohort.Comparison of serological tests for detection of immunoglobulin M antibodies to Chlamydophila pneumoniae.Infectious risk factors for atherosclerotic vascular disease in hemodialysis patients--Chlamydia pneumoniae but not Helicobacter pylori or cytomegalovirus is associated with increased C-reactive protein.Importance of methodology in determination of Chlamydia pneumoniae seropositivity in healthy subjects and in patients with coronary atherosclerosis.Detection of Chlamydia pneumoniae-specific antibodies binding to the VD2 and VD3 regions of the major outer membrane protein.The association between serological features of chronic Chlamydia pneumoniae infection and markers of systemic inflammation and nutrition in COPD patients.
P2860
Q33355197-E1B18471-ADBF-4475-9FDF-F4716B27497AQ33788646-9144B28E-E598-47B8-89C8-BE014E2835ADQ34579563-3100249E-B210-4363-AE94-392CE0B3A731Q34781808-0940382A-5873-47CA-860A-2CD483032FBDQ35023288-88A38951-6B87-4C3D-B2D8-79B148E8C3EEQ35149579-69C3C374-2E11-49F9-9E82-A171D845DFEFQ35523803-0235F4E5-C850-40D6-8017-D1B0CFCC33FAQ36715394-D10238D1-1E3C-4965-8B7C-4CCC88C45539Q37851037-1276E0DA-F1AA-40CE-8BC6-92C179E71A1BQ37857696-3AA1BFB5-6145-4DCB-A38B-16A01FEC791FQ37866530-841C1098-DA32-40B6-853B-40D6ECC5270FQ37868658-FF890EFD-2854-4865-A3E7-3EB37ED6BA84Q37869499-BA86439D-E4E9-49DD-A3FC-323C5EBFDA67Q44059163-23689FF6-82DF-4B4A-AD0A-01961602264C
P2860
Comparison of eleven commercial tests for Chlamydia pneumoniae-specific immunoglobulin G in asymptomatic healthy individuals.
description
2002 nî lūn-bûn
@nan
2002 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Comparison of eleven commercia ...... mptomatic healthy individuals.
@ast
Comparison of eleven commercia ...... mptomatic healthy individuals.
@en
Comparison of eleven commercia ...... mptomatic healthy individuals.
@nl
type
label
Comparison of eleven commercia ...... mptomatic healthy individuals.
@ast
Comparison of eleven commercia ...... mptomatic healthy individuals.
@en
Comparison of eleven commercia ...... mptomatic healthy individuals.
@nl
prefLabel
Comparison of eleven commercia ...... mptomatic healthy individuals.
@ast
Comparison of eleven commercia ...... mptomatic healthy individuals.
@en
Comparison of eleven commercia ...... mptomatic healthy individuals.
@nl
P2093
P2860
P1476
Comparison of eleven commercia ...... mptomatic healthy individuals.
@en
P2093
Annemarie Groh
Corinna Hermann
Eberhard Straube
Kathrin Graf
Thomas Hartung
P2860
P304
P356
10.1128/JCM.40.5.1603-1609.2002
P407
P577
2002-05-01T00:00:00Z